Eric Venker Roivant Sciences Ltd. (ROIV) insider trading activity

Eric Venker is President & Immunovant CEO of Roivant Sciences Ltd.. Currently has a direct ownership of 1.65 Million shares of ROIV, which is worth approximately $23.1 Million. The most recent transaction as insider was on Aug 20, 2025, when has been sold 7,051 shares (Common Shares) at a price of $11.72 per share, resulting in proceeds of $82,637. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.65M

13.09% 3M change

158.63% 12M change

Total Value Held $23.1 Million

Eric Venker Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 20 2025	SELL Payment of exercise price or tax liability	$82,637 $11.72 p/Share	7,051 Reduced 0.42%	1,653,585 Common Shares
Aug 20 2025	SELL Open market or private sale	$1,172,000 $11.72 p/Share	100,000 Reduced 5.7%	1,653,585 Common Shares
Aug 20 2025	BUY Exercise of conversion of derivative security	$385,000 $3.85 p/Share	100,000 Added 5.39%	1,753,585 Common Shares
Jul 30 2025	BUY Grant, award, or other acquisition	-	198,413 Added 10.67%	1,660,636 Common Shares
Jul 21 2025	SELL Open market or private sale	$1,152,000 $11.52 p/Share	100,000 Reduced 6.4%	1,462,223 Common Shares
Jul 21 2025	BUY Exercise of conversion of derivative security	$385,000 $3.85 p/Share	100,000 Added 6.02%	1,562,223 Common Shares
Jun 20 2025	SELL Open market or private sale	$1,145,000 $11.45 p/Share	100,000 Reduced 6.4%	1,462,223 Common Shares
Jun 20 2025	BUY Exercise of conversion of derivative security	$385,000 $3.85 p/Share	100,000 Added 6.02%	1,562,223 Common Shares
Jun 03 2025	SELL Open market or private sale	$6,353,639 $11.22 p/Share	566,278 Reduced 27.92%	1,462,223 Common Shares
Jun 03 2025	BUY Exercise of conversion of derivative security	$3,022,350 $3.85 p/Share	785,026 Added 27.9%	2,028,501 Common Shares
Jun 02 2025	SELL Open market or private sale	$4,801,302 $11.07 p/Share	433,722 Reduced 25.86%	1,243,475 Common Shares
Jun 02 2025	BUY Exercise of conversion of derivative security	$2,310,000 $3.85 p/Share	600,000 Added 26.35%	1,677,197 Common Shares
May 20 2025	SELL Payment of exercise price or tax liability	$432,193 $11.04 p/Share	39,148 Reduced 3.51%	1,077,197 Common Shares
May 20 2025	SELL Open market or private sale	$1,095,000 $10.95 p/Share	100,000 Reduced 8.49%	1,077,197 Common Shares
May 20 2025	BUY Exercise of conversion of derivative security	$385,000 $3.85 p/Share	100,000 Added 7.83%	1,177,197 Common Shares
Apr 21 2025	SELL Open market or private sale	$1,022,000 $10.22 p/Share	100,000 Reduced 8.22%	1,116,345 Common Shares
Apr 21 2025	BUY Exercise of conversion of derivative security	$385,000 $3.85 p/Share	100,000 Added 7.6%	1,216,345 Common Shares
Apr 20 2025	SELL Payment of exercise price or tax liability	$111,091 $10.15 p/Share	10,945 Reduced 0.97%	1,116,345 Common Shares
Mar 24 2025	SELL Open market or private sale	$4,701,051 $10.82 p/Share	434,478 Reduced 27.82%	1,127,290 Common Shares
Mar 24 2025	BUY Exercise of conversion of derivative security	$2,318,897 $3.85 p/Share	602,311 Added 27.83%	1,561,768 Common Shares
Mar 20 2025	SELL Open market or private sale	$3,489,673 $11.06 p/Share	315,522 Reduced 24.75%	959,457 Common Shares
Mar 20 2025	SELL Payment of exercise price or tax liability	$120,066 $10.97 p/Share	10,945 Reduced 1.24%	874,979 Common Shares
Mar 20 2025	BUY Exercise of conversion of derivative security	$1,540,000 $3.85 p/Share	400,000 Added 23.88%	1,274,979 Common Shares
Feb 20 2025	SELL Payment of exercise price or tax liability	$117,330 $10.72 p/Share	10,945 Reduced 1.22%	885,924 Common Shares
Feb 20 2025	SELL Open market or private sale	$1,065,000 $10.65 p/Share	100,000 Reduced 10.03%	896,869 Common Shares

Also insider at

IMVT

Immunovant, Inc. Healthcare

Chief Executive Officer

Eric Venker

President & Immunovant CEO

London, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ROIV shares.

Notify only if

Value

Insider Trading

Get notified when an Roivant Sciences Ltd. insider buys or sells ROIV shares.

Notify only if

Operation

Value

Type

News

Receive news related to Roivant Sciences Ltd.

Track Activities on ROIV

Account